FATTY LIVER, NON-ALCOHOLIC FATTY LIVER DISEASE, NAFLD
Clinical trials for FATTY LIVER, NON-ALCOHOLIC FATTY LIVER DISEASE, NAFLD explained in plain language.
Never miss a new study
Get alerted when new FATTY LIVER, NON-ALCOHOLIC FATTY LIVER DISEASE, NAFLD trials appear
Sign up with your email to follow new studies for FATTY LIVER, NON-ALCOHOLIC FATTY LIVER DISEASE, NAFLD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Reishi mushroom tested as fatty liver treatment in new study
Disease control ENROLLING_BY_INVITATIONThis study tests whether Ganoderma lucidum (a type of mushroom) can improve antioxidant levels and liver health in people with Metabolic Associated Fatty Liver Disease (MAFLD). Forty adults aged 35-49 with early-stage fatty liver will take the mushroom supplement. Researchers wil…
Matched conditions: FATTY LIVER, NON-ALCOHOLIC FATTY LIVER DISEASE, NAFLD
Phase: NA • Sponsor: University of Agriculture, Peshawar • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New scan reveals hidden metabolic clues in fatty liver disease
Knowledge-focused OngoingThis study uses advanced full-body PET scans to see how the body handles sugar and amino acids in healthy people and those with non-alcoholic fatty liver disease (NAFLD). About 36 adults aged 18-70 will receive a radioactive tracer by mouth or IV and have scans to track nutrient …
Matched conditions: FATTY LIVER, NON-ALCOHOLIC FATTY LIVER DISEASE, NAFLD
Phase: NA • Sponsor: Rigshospitalet, Denmark • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC